Home Your basket
• Hypersensitivity to inhal...
   Price 10.50 €
• Postural study on healthy...
   Price 10.50 €
• Evaluation of the efficie...
   Price 10.50 €
• Laryngeal tuberculosis: A...
   Price 5.50 €
• Lipoma of the larynx: Fib...
   Price 8.00 €
• Tuberculosis of the parot...
   Price 5.50 €
• Oropharyngeal reconstruct...
   Price 10.50 €
• Recent advances in surger...
   Price 5.50 €
• Meniere disease : news....
   Price 10.50 €
• Induction chemotherapy an...
   Price 10.50 €
• Role of diffusion weighte...
   Price 10.50 €
• Primary nasal tuberculosi...
   Price 5.50 €
• Diagnosis management of W...
   Price 10.50 €
• When some clinical cases ...
   Price 8.50 €
• Eagle syndrom: A case rep...
   Price 8.50 €
• Exploration of the otolit...
   Price 10.50 €
• An unusual fester of the ...
   Price 8.50 €
• Nasal cutaneous cryptococ...
   Price 5.50 €
• Early evaluation of voice...
   Price 12.00 €
• A case of nasal NK/T cell...
   Price 5.50 €
• A rare and unusual cause ...
   Price 8.50 €
• Ossicular reconstruction ...
   Price 10.50 €
• Subcutaneous emphysema an...
   Price 5.50 €
• Voice rehabilitation afte...
   Price 10.50 €
• Deafness in adults. Study...
   Price 10.50 €
• Middle ear tuberculosis e...
   Price 5.50 €
• Medial displacement of T-...
   Price 8.50 €
• Use of inomeric cement: P...
   Price 10.50 €
• Isolated tracheo-œsophage...
   Price 5.50 €
• Botulinum toxin, descript...
   Price 12.50 €
• Changing patterns of bucc...
   Price 10.50 €
• Results of six years expe...
   Price 8.50 €
• Interest of hypnotherapy ...
   Price 10.50 €
• Eye rings: Morphological ...
   Price 10.50 €

Total Order 301.00 €

contents
2019
   N# 1 |
2018
   N# 1 | 2 | 3 | 4 | 5 |
2017
   N# 1 | 2 | 3 | 4 | 5 |
2016
   N# 1 | 2 | 3 | 4 | 5 |
2015
   N# 1 | 2 | 3 | 4 | 5 |
2014
   N# 1 | 2 | 3 | 4 | 5 |
2013
   N# 1 | 2 | 3 | 4 | 5 |
2012
   N# 1 | 2 | 3 | 4 | 5 |
2011
   N# 1 | 2 | 3 | 4 | 5 |
2010
   N# 1 | 2 | 3 | 4 | 5 |
2009
   N# 1 | 2 | 3 | 4 | 5 |
2008
   N# 1 | 2 | 3 | 4 | 5 |
2007
   N# 1 | 2 | 3 | 4 | 5 |
2006
   N# 1 | 2 | 3 | 4 | 5 |
2005
   N# | 1 | 2 | 3 | 4 | 5 |
2004
   N# 1 | 2 | 3 | 4 | 5 |
2003
   N# 1 | 2 | 3 | 4 | 5 |
2002
   N# 1 | 2 | 3 | 4 | 5 |
2001
   N# 1 | 2 | 3 | 4 | 5 |
2000
   N# | 1 | 2 | 3 | 4 | 5 |
1999
   N# 1 | 2 | 3 | 4 | 5 |
1998
   N# 1 | 2 | 3 | 5 |
1997
   N# 1 | 2 | 3 | 4 | 5 |
1996
   N# 4 | 5 |

Click on the number of the review to see the content
Teaching bulletin CME
List of all teaching bulletins CME.
Editor reading committee
Editor reading committee.
To publish...
Instructions for authors
Archives Press and Books
Select of books and press articles.
Mailing list
News information letter.
Subscription prices


If you wish to adjust the size of the displayed characters, click in the high menu on "Your account" and choose the desired size.



  Contents > Previous page > Article detail print Order
o Issue N# 3 - 2008 o

CERVICO-FACIAL CARCINOLOGY

Sarcomatoid carcinomas of the upper airways


Authors : Oueslati Z, Ben Miled M, Hammoud M, Touati S, Lachkham A, Gamoudi A, Mokni N, El Benna F, Boussen H, El May A, Ladgham A. (Tunis)

Ref. : Rev Laryngol Otol Rhinol. 2008;129,3:191-195.

Article published in french
Downloadable PDF document french



Summary : Introduction: The sarcomatoid carcinoma of the superior aerodigestive tracts is a rare malignant tumour, which presents diagnostic and therapeutic challenges. Material and method: We report 11 cases of spindle cell carcinomas of the upper airways. Results: Sex-ratio was 10:1 and the mean age was 57.3 years (30 - 75 years). Nine patients were smokers and 4 presented with a history of radiation exposure. Tumoral locations were as follows: larynx: 6, hypopharynx: 1, oropharynx: 1, nasopharynx: 1, oral cavity: 2. Histological diagnosis in 3 cases required the use of immunohistochemical studies. Four patients were first seen at an advanced stage. This left 9 patients and among them 7 received a curative treatment: 5 by surgery alone, 1 by surgery and radiotherapy, 1 by radiotherapy, 1 by chemo-radiotherapy for the nasopharyngeal lesion and 1 by chemotherapy alone. Two patients died from their disease before treatment. With an average delay of 15.4 months, the rates of global survival and disease-free were 5/9 and 4/9 respectively. Conclusion: The sarcomatoid carcinoma of the upper airways is rare, but not unusual. Its diagnosis benefits from progresses in immunohistochemistry, but also from advances in the field of molecular biology. Its treatment and natural evolution remain controversial.

Price : 10.50 €      order
|


Subscribe online - Pay by credit card!


© Copyright 1999-2024 - Revue de Laryngologie   Réalisation - Hébergement ELIDEE